Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta-analysis

Thomas, J., Kamso, M. M., Whittle, S. L., Wells, G. A., Kelly, S. E., Pardo Pardo, J., Tugwell, P., Johnston, R. V., Glennon, V., Ejaredar, M., Thomas, M., Lee, C., Elliott, J., Mokbel, A., Avery, J. C., Grobler, L., Cyril, S., Deardon, R., Akl, E. A., Maxwell, L. J., … Supported by the Cochrane Musculoskeletal Health and Pain Thematic Group (2026). Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta-analysis. The Cochrane database of systematic reviews, 7(7), CD013562. https://doi.org/10.1002/14651858.CD013562.pub2